We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DCPH market cap is 1.15B. The company's latest EPS is USD -2.4126 and P/E is -5.90.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 35.97M | 36.35M | 33.45M | 38.3M | 43.31M |
| Operating Income | -44.88M | -47.16M | -53.26M | -52.78M | -53.69M |
| Net Income | -43.04M | -45.94M | -49.61M | -48.56M | -49.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 25M | 42.09M | 96.15M | 134.04M | 163.36M |
| Operating Income | -200.73M | -271.19M | -300.08M | -182.72M | -210.96M |
| Net Income | -192.26M | -266.49M | -299.96M | -178.93M | -194.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 475.95M | 454.04M | 549.02M | 509.62M | 497.84M |
| Total Liabilities | 102.18M | 112.35M | 108.94M | 105.19M | 116.17M |
| Total Equity | 373.78M | 341.69M | 440.08M | 404.43M | 381.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 622.41M | 642.43M | 429.48M | 454.04M | 473.57M |
| Total Liabilities | 75.94M | 98.76M | 124.76M | 112.35M | 122.65M |
| Total Equity | 546.47M | 543.68M | 304.72M | 341.69M | 350.92M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -117.7M | -152.86M | -49.46M | -88.08M | -117.89M |
| Investing | -50.61M | -34.31M | -35.41M | -31.05M | 10.35M |
| Financing | 164.52M | 164.99M | 134.69M | 135.52M | 151.11M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -149.3M | -239.68M | -240.82M | -152.86M | -146.7M |
| Investing | -460.52M | 28.46M | 176.85M | -34.31M | 12.55M |
| Financing | 436.37M | 226.8M | 14.89M | 164.99M | 152M |
| Market Cap | 1.15B |
| Price to Earnings Ratio | -5.90 |
| Price to Sales Ratio | 7.04 |
| Price to Cash Ratio | 13.77 |
| Price to Book Ratio | 3.28 |
| Dividend Yield | - |
| Shares Outstanding | 80.8M |
| Average Volume (1 week) | 461.3k |
| Average Volume (1 Month) | 448.19k |
| 52 Week Change | -4.30% |
| 52 Week High | 17.73 |
| 52 Week Low | 9.90 |
| Spread (Intraday) | 2 (12.5%) |
| Company Name | Deciphera Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.deciphera.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
